2013-03-05 13:32:12 -
Menlo Park, Calif., March 5, 2013 - Geron Corporation (Nasdaq: GERN) will
announce its financial results for the fourth quarter and year ended December
31, 2012, on Tuesday, March 12, 2013, after the market close. Geron's management
will host a conference call for analysts and investors on Wednesday, March
13, 2013, at 9:00 a.m. Eastern Time to discuss the company's fourth quarter and
annual results and highlights.
Participants can access the conference call live via telephone by dialing
866-270-6057 (U.S.); 617-213-8891 (international). The passcode is 80790305. If
accessing the conference call by telephone, please dial in at least 10 minutes
early to minimize any delay in joining the call. A live audio-only webcast is
also available at edge.media-server.com/m/p/3328hz6w/lan/en. The audio
webcast of the conference call will be available for replay
hour following the live broadcast through April 12, 2013.
Geron is a biopharmaceutical company developing first-in-class therapies for
cancer, including its telomerase inhibitor, imetelstat, in clinical development.
For more information about Geron, visit www.geron.com.
Anna Krassowska, Ph.D.
Investor and Media Relations
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Geron Corp. via Thomson Reuters ONE